Interim analysis of companion, prospective, phase II, clinical trials assessing the efficacy and safety of multi-modal total eradication therapy in men with synchronous oligometastatic prostate cancer. - Reyes DK; Trock BJ; Tran PT; Pavlovich CP; Deville C; Allaf ME; Greco SC; Song DY; Bivalacqua TJ; Han M; Partin AW; Sartor AO; et al. (Medical oncology (Northwood, London, England), 2022)